The main European indexes have evolved shortly tomorrow tomorrow. The quarterly seasonal win starts in the United States. Brussels is separated.
• Euronext Brussels
Very few changes further European markets this Tuesday afternoon as the season's quarterly gain starts in the US and coming soon to us.
Brussels again emphasizes. About 12:10 p.m., the Bel 20
grew 0.31%, with the less acute advance (+ 0.10%) for the index of constantly quoted securities.
Aperam led the increase (+ 2.6%) followed by Solvay (+ 1%) and Argenx (+ 0.9%). AB InBev (+ 0.4%) will slowly retrieve its Asian successor.
GalapagosOn the other hand, after a small weakness agreement early in the session, the road to the rise (+ 0.5%) began to reign.
Colruyt and Boat, Which publishes its average numbers on Thursday morning, divides the red lantern with a decrease of one percent.
For Bel 20, Mitro climbed 4.4%. In addition, biopharma has announced reinforcement of its administration. In the same compartment, Oxurion jumped 9% without obvious explanation and Kiadis takes 2%.
At the bottom of the table, we'll bite GenKyoTex (-4.8%) Hamon (-3.6%) and Smartphoto (-2.2%).
• The Belgian activities on summary
: ABN Amro reduced his target performance to 17.5 euros versus 18 euros previously. The recommendation remains "to buy".
: Degroof Petercam lowered its recommendation "to accumulate" against "to buy" before. The deadline is at 28 euros.
* HC Wainwright raised its price for a US certification at $ 205 for $ 150 before. The recommendation remains "to buy".
* Raymond James lowered his recommendation to "neutral" against "strong purchase" before.
Kempen raised his performance at 180 euros versus 135 euros before. The recommendation remains "to buy".
acquired, in the last week, 170,000 own shares at a median price price of 47.96 euros.
> The soldier of Marshall Wace Colruyt
fell by the reporting threshold of 0.50% of capital on July 12 against a position of 0.59% earlier.
won the last week 802,559 own shares at a median price price of 20.19 euros.
appointed a new chief scientific officer and plant leader to support its CDMO strategy. The edition
contrary to the order, which forces it to publish documents. Nyrstar signed a process against the order to issue documents. The company challenges the interpretation of lawyers. Our article
won 141.8 million euros with a bond issued in a Swedish colonel. The funds will be used to buy the Ellos group.
>To watch this morning. Germany. Investor-confidence (ZEW) in July (at 11.00). Eurozone. Commercial balance in May (at 11.00). United States. Retail business in June (at 14:30). Industry production in June (at 15:15 hours). Results: JP Morgan Chase, Johnson & Johnson, Goldman Sachs and Wells Fargo.